sales, strongest profit ever in 2025 Hanmi Pharm signs exclusive Mexico deal for GLP-1 obesity drug efpeglenatide Hanmi files for approval of new GLP-1 weight-loss shot, tees up diabetes and DTx expansions Roche companies, Korean Diabetes Association team up on diabetes care Novo Nordisk wins Korean approval for once-weekly insulin-GLP-1 combo Kyinsu [Column] Innovative diabetes drugs still out of reach for patients who need them most [Column] Mounjaro's reimbursement failure: Whose responsibility is it
[3] How GLP-1 Patches Work (or Dont) GLP-1 patches are transdermal systems, similar in concept to nicotine or hormone patches
In rare cases, more serious risks can occur, such as pancreatitis, acute kidney injury, gallbladder issues
Avoid freezing the reconstituted solution, since freezethaw can denature the peptide
Non-diabetic patients actually avoid hypoglycemia risks that diabetic users face, though they still require medical supervision for dose adjustment and side effect management